# Yunhu Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yunhu-health

- Industry: Healthcare IT
- Headquarters: Hangzhou, China
- Website: www.yunhuyj.com
- Total disclosed funding: $7.5M
- Latest round: Series A (Mar 13, 2019)
- Investors on record: 5

## About

Yunhu Health is a health technology company specializing in innovative medical examination services through an online platform that offers remote health assessments, enhancing healthcare accessibility for users and organizations alike.Founded in 2017 and headquartered in Hangzhou, China, Yunhu Health operates through its platform, E???, which provides remote medical examination services. The company has raised a total of CNY 220.00 mn during its funding rounds, with the most recent round occurring in September 2019, led by ZWC Ventures alongside other investors such as BioTrack Capital and CASH Capital. The CEO and founder, Xiaobing Chen, has a history of engaging in health technology initiatives and has successfully directed the company through its early growth phases.E??? specializes in delivering advanced medical examination services via its online platform, which allows users to undergo remote health assessments without needing to visit healthcare facilities. This service caters to both individual consumers seeking personal health insights and businesses that implement health management for their workforce, primarily targeting urban areas in China where demand for efficient healthcare solutions is increasing.The revenue model of E??? is based on subscription services and direct transactions, offering various health examination packages tailored to individual users and corporate clients. Businesses typically subscribe to comprehensive health screening services for their employees, while individual users can access a selection of health examination services with transparent pricing, ensuring sustained revenue generation and improved healthcare service accessibility.In September 2019, Yunhu Health secured CNY 220.00 mn in funding to enhance its operations and expand its market reach. The company is focusing on developing new health examination products and is planning to extend its services beyond urban centers in China towards more rural regions. This strategic expansion aims to increase healthcare accessibility and efficiency while utilizing recent funding to support these initiatives.

## Funding rounds

- Series A, Mar 13, 2019 — Vision Capital, 5Y Capital, CASH Capital, Cyber Creation Ventures (CCV), BioTrack Capital
- Series A, Jul 1, 2018, $7.5M — CASH Capital, BioTrack Capital

## Investors

- CASH Capital (https://capitalatlas.ai/funds/cash-capital) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A
- Vision Capital — Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- Cyber Creation Ventures (CCV) (https://capitalatlas.ai/funds/cyber-creation-ventures-ccv) — Series A